Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Microsomal triglyceride transfer protein polymorphism (-493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C.

Mirandola S, Osterreicher CH, Marcolongo M, Datz C, Aigner E, Schlabrakowski A, Realdon S, Gerotto M, Alberti A, Stickel F.

Liver Int. 2009 Apr;29(4):557-65. doi: 10.1111/j.1478-3231.2008.01892.x. Epub 2008 Oct 10.

PMID:
19018985
2.

Heterogeneity of CK2 phosphorylation sites in the NS5A protein of different hepatitis C virus genotypes.

Dal Pero F, Di Maira G, Marin O, Bortoletto G, Pinna LA, Alberti A, Ruzzene M, Gerotto M.

J Hepatol. 2007 Dec;47(6):768-76. Epub 2007 Sep 24.

PMID:
17923166
3.

Impact of NS5A sequences of Hepatitis C virus genotype 1a on early viral kinetics during treatment with peginterferon- alpha 2a plus ribavirin.

Dal Pero F, Tang KH, Gerotto M, Bortoletto G, Paulon E, Herrmann E, Zeuzem S, Alberti A, Naoumov NV.

J Infect Dis. 2007 Oct 1;196(7):998-1005. Epub 2007 Aug 21.

PMID:
17763320
4.

Analysis of immunoglobulin variable kappa gene mutations in cutaneous B-cell lymphoma.

Bortoletto G, Gerotto M, Pigozzi B, Michelotto A, Alberti A, Vezzi A, Alaibac M.

J Dermatol Sci. 2007 Sep;47(3):248-52. Epub 2007 Jun 27. No abstract available.

PMID:
17600686
5.

Evolution of hepatitis C virus quasispecies in children with chronic hepatitis C.

Gerotto M, Resti M, Dal Pero F, Migliorato I, Alberti A, Bortolotti F.

Infection. 2006 Apr;34(2):62-5.

PMID:
16703294
6.

Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.

Mirandola S, Realdon S, Iqbal J, Gerotto M, Dal Pero F, Bortoletto G, Marcolongo M, Vario A, Datz C, Hussain MM, Alberti A.

Gastroenterology. 2006 May;130(6):1661-9. Epub 2006 Mar 6.

PMID:
16697730
7.

Detailed analysis of the E2-IgM complex in hepatitis C-related type II mixed cryoglobulinaemia.

Ferri S, Dal Pero F, Bortoletto G, Bianchi FB, Lenzi M, Alberti A, Gerotto M.

J Viral Hepat. 2006 Mar;13(3):166-76.

PMID:
16475992
8.

Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapse.

Gerotto M, Dal Pero F, Bortoletto G, Ferrari A, Pistis R, Sebastiani G, Fagiuoli S, Realdon S, Alberti A.

J Hepatol. 2006 Jan;44(1):83-7. Epub 2005 Sep 21.

PMID:
16271794
9.

PKR gene expression and response to pegylated interferon plus ribavirin therapy in chronic hepatitis C.

Gerotto M, Dal Pero F, Bortoletto G, Realdon S, Ferrari A, Boccato S, Alberti A.

Antivir Ther. 2004 Oct;9(5):763-70.

PMID:
15535414
10.

Hepatitis C virus quasispecies in the natural course of HCV-related disease in patients with haemophilia.

Tagariello G, Gerotto M, Pontisso P, Belvini D, Salviato R, Radossi P, Alberti A.

Haemophilia. 2004 Jan;10(1):81-6.

PMID:
14962225
11.

Proapoptotic effect of hepatitis C virus CORE protein in transiently transfected cells is enhanced by nuclear localization and is dependent on PKR activation.

Realdon S, Gerotto M, Dal Pero F, Marin O, Granato A, Basso G, Muraca M, Alberti A.

J Hepatol. 2004 Jan;40(1):77-85.

PMID:
14672617
12.

Assessment of heavy metal background values in the soils of inland coastal areas of Venice, Italy.

Scazzola R, Avezz├╣ S, Biancotto R, Chiamenti E, Chiozzotto E, Gerotto M, Palonta M, Roiter S.

Ann Chim. 2003 Apr;93(4):465-70.

PMID:
12817647
13.

A 385 insertion in the hypervariable region 1 of hepatitis C virus E2 envelope protein is found in some patients with mixed cryoglobulinemia type 2.

Gerotto M, Dal Pero F, Loffreda S, Bianchi FB, Alberti A, Lenzi M.

Blood. 2001 Nov 1;98(9):2657-63.

PMID:
11675335
14.

Two PKR inhibitor HCV proteins correlate with early but not sustained response to interferon.

Gerotto M, Dal Pero F, Pontisso P, Noventa F, Gatta A, Alberti A.

Gastroenterology. 2000 Dec;119(6):1649-55.

PMID:
11113086
15.

Coinfection by hepatitis B virus and hepatitis C virus.

Pontisso P, Gerotto M, Benvegn├╣ L, Chemello L, Alberti A.

Antivir Ther. 1998;3(Suppl 3):137-42. Review.

PMID:
10726063
16.

The molecular basis for responsiveness to anti-viral therapy in hepatitis C.

Polyak SJ, Gerotto M.

Forum (Genova). 2000 Jan-Mar;10(1):46-58. Review.

PMID:
10717257
17.

Evidence for sequence selection within the non-structural 5A gene of hepatitis C virus type 1b during unsuccessful treatment with interferon-alpha.

Gerotto M, Dal Pero F, Sullivan DG, Chemello L, Cavalletto L, Polyak SJ, Pontisso P, Gretch DR, Alberti A.

J Viral Hepat. 1999 Sep;6(5):367-72.

PMID:
10607252
18.

Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C.

Gerotto M, Sullivan DG, Polyak SJ, Chemello L, Cavalletto L, Pontisso P, Alberti A, Gretch DR.

J Virol. 1999 Sep;73(9):7241-7.

19.

[Environmental lead exposure in the Venetian population from 1976-1992].

Bortoli A, Gerotto M, Marchiori M, Palonta M, Troncon A, Chiodo F.

Ann Ist Super Sanita. 1998;34(1):59-65. Italian.

PMID:
9679341
20.

Characteristics of hepatitis C virus before and after interferon treatment in patients with ongoing viraemia but sustained biochemical response.

Donadel E, Pontisso P, Ruvoletto MG, Gerotto M, De Salvo G, Chemello L, Casarin C, Alberti A.

J Med Virol. 1998 Jan;54(1):7-11.

PMID:
9443103
21.

In vivo translational efficiency of different hepatitis C virus 5'-UTRs.

Buratti E, Gerotto M, Pontisso P, Alberti A, Tisminetzky SG, Baralle FE.

FEBS Lett. 1997 Jul 14;411(2-3):275-80.

22.

Endogenous interferon-alpha concentration and outcome of interferon treatment in patients with chronic hepatitis C.

Pirisi M, Fabris C, Toniutto P, Falleti E, Tisminetzky SG, Gerotto M, Soardo G, Vitulli D, Del Forno M, Baralle F, Bartoli E.

Dig Dis Sci. 1997 Apr;42(4):767-71.

PMID:
9125646
24.

Discordant results from hepatitis C virus genotyping by procedures based on amplification of different genomic regions.

Toniutto P, Pirisi M, Tisminetzky SG, Fabris C, Chinellato E, Gerotto M, Falleti E, Ferroni P, Lombardelli T, Bartoli E, Baralle F.

J Clin Microbiol. 1996 Oct;34(10):2382-5.

25.

Hepatitis C genotypes in patients with dual hepatitis B and C virus infection.

Pontisso P, Gerotto M, Ruvoletto MG, Fattovich G, Chemello L, Tisminetzky S, Baralle F, Alberti A.

J Med Virol. 1996 Feb;48(2):157-60.

PMID:
8835349
26.

Comparison of genotyping and serotyping methods for the identification of hepatitis C virus types.

Tisminetzky S, Gerotto M, Pontisso P, Chemello L, Prescott LE, Rose KA, Baralle F, Simmonds P, Alberti A.

J Virol Methods. 1995 Nov;55(3):303-7.

PMID:
8609196
27.

Hepatitis C virus genotypes HCV-1a and HCV-1b: the clinical point of view.

Pontisso P, Gerotto M, Chemello L, Casarin C, Tisminetzky S, Baralle F, Alberti A.

J Infect Dis. 1995 Mar;171(3):760. No abstract available.

PMID:
7533200
28.

Analytical problems in mercury analysis of seafood.

Bortoli A, Gerotto M, Marchiori M, Palonta M, Troncon A.

Ann Ist Super Sanita. 1995;31(3):359-62.

PMID:
8712580
29.

Distribution of three major hepatitis C virus genotypes in Italy. A multicentre study of 495 patients with chronic hepatitis C.

Pontisso P, Ruvoletto MG, Nicoletti M, Tisminetzky S, Gerotto M, Levrero M, Artini M, Baldi M, Ballardini G, Barbara L, et al.

J Viral Hepat. 1995;2(1):33-8.

PMID:
7493292
30.

Analysis of the hepatitis C virus genome in patients with anti-LKM-1 autoantibodies.

Gerotto M, Pontisso P, Giostra F, Francesconi R, Muratori L, Ballardini G, Lenzi M, Tisminetzky S, Bianchi FB, Baralle FB, et al.

J Hepatol. 1994 Aug;21(2):273-6.

PMID:
7989722

Supplemental Content

Loading ...
Support Center